We, therefore, evaluated AHR protein levels in a cohort of documented aflatoxin-associated liver cancers (AF-HCC) from patients with detectable levels of Aflatoxin M1 in their urine samples (Table 1 and Supplementary Table S5). The gene discussed is AHR; the disease is hepatocellular carcinoma.